التفاصيل البيبلوغرافية
| العنوان: |
Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). |
| المؤلفون: |
Patrikidou, Anna, Chaigneau, Loic, Isambert, Nicolas, Kitikidou, Kyriaki, Shanley, Ryan, Ray-Coquard, Isabelle, Valentin, Thibaud, Malivoir, Bettina, Laigre, Maryline, Bay, Jacques-Olivier, Moureau-Zabotto, Laurence, Bompas, Emmanuelle, Piperno-Neumann, Sophie, Penel, Nicolas, Alcindor, Thierry, Guillemet, Cécile, Duffaud, Florence, Hügli, Anne, Le Pechoux, Cécile, Dhermain, Frédéric |
| المصدر: |
BMC Cancer; 2/12/2020, Vol. 20 Issue 1, p1-11, 11p, 1 Diagram, 4 Charts, 1 Graph |
| مصطلحات موضوعية: |
BRAIN metastasis, SARCOMA, BRAIN damage, MENINGEAL cancer |
| مستخلص: |
Background: Brain metastases from sarcomatous lesions pose a management challenge owing to their rarity and the histopathological heterogeneity. Prognostic indices such as the Graded Prognostic Assessment (GPA) index have been developed for several primary tumour types presenting with brain metastases (e.g. lung, breast, melanoma), tailored to the specifics of different primary histologies and molecular profiles. Thus far, a prognostic index to direct treatment decisions is lacking for adult sarcoma patients with brain metastases.Methods: We performed a multicentre analysis of a national group of expert sarcoma tertiary centres (French Sarcoma Group, GSF-GETO) with the participation of one Canadian and one Swiss centre. The study cohort included adult patients with a diagnosis of a bone or soft tissue sarcoma presenting parenchymal or meningeal brain metastases, managed between January 1992 and March 2012. We assessed the validity of the original GPA index in this patient population and developed a disease-specific Sarcoma-GPA index.Results: The original GPA index is not prognostic for sarcoma brain metastasis patients. We have developed a dedicated Sarcoma-GPA index that identifies a sub-group of patients with particularly favourable prognosis based on histology, number of brain lesions and performance status.Conclusions: The Sarcoma-GPA index provides a novel tool for sarcoma oncologists to guide clinical decision-making and outcomes research. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder